Half-year report · HY

Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.1bn2025-06-01 → 2025-11-30Cons.Net sales
Revenue¥23.7bn2024-06-01 → 2025-05-31Cons.Net sales (5-year summary)
Revenue¥11.7bn2024-06-01 → 2024-11-30Cons.Net sales
Operating income¥1.1bn2025-06-01 → 2025-11-30Cons.Operating income
Operating income¥879m2024-06-01 → 2024-11-30Cons.Operating income
Ordinary income¥1.2bn2025-06-01 → 2025-11-30Cons.Ordinary income
Ordinary income¥2.0bn2024-06-01 → 2025-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥906m2024-06-01 → 2024-11-30Cons.Ordinary income
Profit before tax¥1.3bn2025-06-01 → 2025-11-30Cons.Income before income taxes
Profit before tax¥906m2024-06-01 → 2024-11-30Cons.Income before income taxes
Net income (owners)¥912m2025-06-01 → 2025-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2024-06-01 → 2025-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥608m2024-06-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income¥912m2025-06-01 → 2025-11-30Cons.Profit loss
Net income¥608m2024-06-01 → 2024-11-30Cons.Profit loss
Total assets¥23.8bnat 2025-11-30Cons.Assets
Total assets¥22.6bnat 2025-05-31Cons.Assets
Total assets¥23.3bnat 2024-11-30Cons.Total assets (5-year summary)
Total liabilities¥8.2bnat 2025-11-30Cons.Liabilities
Total liabilities¥7.8bnat 2025-05-31Cons.Liabilities
Net assets / equity¥15.6bnat 2025-11-30Cons.Net assets
Net assets / equity¥14.8bnat 2025-05-31Cons.Net assets
Net assets / equity¥13.8bnat 2024-11-30Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2025-11-30Cons.Cash and deposits
Cash and deposits¥6.8bnat 2025-05-31Cons.Cash and deposits
Cash & equivalents¥6.9bnat 2025-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2025-05-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2024-05-31vCons.Cash and cash equivalents
Operating cash flow¥1.1bn2025-06-01 → 2025-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.0bn2024-06-01 → 2025-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥310m2024-06-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥76m2025-06-01 → 2025-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥420m2024-06-01 → 2025-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥358m2024-06-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥573m2025-06-01 → 2025-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥946m2024-06-01 → 2025-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥425m2024-06-01 → 2024-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥154.312025-06-01 → 2025-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥305.842024-06-01 → 2025-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥103.032024-06-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio65.7%at 2025-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio65.3%at 2025-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio59.4%at 2024-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Chemical Businessreportable segmentrevenue2025-06-01 → 2025-11-30¥11.5bn
Chemical Businessreportable segmentrevenue external2025-06-01 → 2025-11-30¥11.5bn
Chemical Businessreportable segmentsegment profit2025-06-01 → 2025-11-30¥996m
Healthcare Businessreportable segmentrevenue2025-06-01 → 2025-11-30¥673m
Healthcare Businessreportable segmentrevenue external2025-06-01 → 2025-11-30¥673m
Healthcare Businessreportable segmentsegment profit2025-06-01 → 2025-11-30¥148m
—segment totalrevenue2025-06-01 → 2025-11-30¥12.1bn
—segment totalrevenue external2025-06-01 → 2025-11-30¥12.1bn
—segment totalsegment profit2025-06-01 → 2025-11-30¥1.1bn
Chemical Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥11.0bn
Chemical Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥11.0bn
Chemical Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥731m
Healthcare Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥671m
Healthcare Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥671m
Healthcare Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥148m
—segment totalrevenue2024-06-01 → 2024-11-30¥11.7bn
—segment totalrevenue external2024-06-01 → 2024-11-30¥11.7bn
—segment totalsegment profit2024-06-01 → 2024-11-30¥879m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 476
ItemContextValueUnit
Interest and dividends income ope cfPrior1InterimDuration-12233000JPY
Interest and dividends income ope cfInterimDuration-25281000JPY
Interest expenses ope cfPrior1InterimDuration3496000JPY
Interest expenses ope cfInterimDuration2857000JPY
Loss gain on sales and retirement of noncurrent assets ope cfPrior1InterimDuration-268000JPY
Loss gain on sales and retirement of noncurrent assets ope cfInterimDuration3529000JPY
Loss gain on sales of subsidiaries stocks ope cfPrior1InterimDuration-JPY
Loss gain on sales of subsidiaries stocks ope cfInterimDuration-92069000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration-596499000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration-373570000JPY
Decrease increase in inventories ope cfPrior1InterimDuration-292841000JPY
Decrease increase in inventories ope cfInterimDuration-200614000JPY
Decrease increase in other current assets ope cfPrior1InterimDuration25942000JPY
Decrease increase in other current assets ope cfInterimDuration-71767000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration240142000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration196580000JPY
Increase decrease in accounts payable other and accrued expenses ope cfPrior1InterimDuration95994000JPY
Increase decrease in accounts payable other and accrued expenses ope cfInterimDuration-5342000JPY
Increase decrease in accrued consumption taxes ope cfPrior1InterimDuration-75472000JPY
Increase decrease in accrued consumption taxes ope cfInterimDuration51905000JPY
Other net ope cfPrior1InterimDuration67627000JPY
Other net ope cfInterimDuration37453000JPY
Subtotal ope cfPrior1InterimDuration602012000JPY
Subtotal ope cfInterimDuration1072672000JPY
Interest and dividends income received ope cf inv cfPrior1InterimDuration12233000JPY
Interest and dividends income received ope cf inv cfInterimDuration25281000JPY
Interest expenses paid ope cf fin cfPrior1InterimDuration-3481000JPY
Interest expenses paid ope cf fin cfInterimDuration-2854000JPY
Income taxes refund ope cfPrior1InterimDuration5000JPY
Income taxes refund ope cfInterimDuration72813000JPY
Income taxes paid ope cfPrior1InterimDuration-301237000JPY
Income taxes paid ope cfInterimDuration-104435000JPY
Net cash provided by used in operating activitiesPrior1InterimDuration309532000JPY
Net cash provided by used in operating activitiesInterimDuration1063477000JPY
Payments into time deposits inv cfPrior1InterimDuration-169280000JPY
Payments into time deposits inv cfInterimDuration-JPY
Purchase of investment securities inv cfPrior1InterimDuration-1542000JPY
Purchase of investment securities inv cfInterimDuration-1615000JPY
Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1InterimDuration-JPY
Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cfInterimDuration-21202000JPY
Purchase of property plant and equipment inv cfPrior1InterimDuration-142539000JPY
Purchase of property plant and equipment inv cfInterimDuration-140498000JPY
Purchase of intangible assets inv cfPrior1InterimDuration-41086000JPY
Purchase of intangible assets inv cfInterimDuration-18242000JPY
Collection of loans receivable inv cfPrior1InterimDuration269000JPY
Collection of loans receivable inv cfInterimDuration105041000JPY
Other net inv cfPrior1InterimDuration-3358000JPY
Other net inv cfInterimDuration1016000JPY
Net cash provided by used in investment activitiesPrior1InterimDuration-357537000JPY
Net cash provided by used in investment activitiesInterimDuration-75501000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-05-31pass rounding
balance sheet identityconsolidated 2025-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-05-31pass
statement vs summary · net assetsconsolidated 2025-11-30pass
statement vs summary · net income attributable to parentconsolidated 2024-06-01/2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2025-06-01/2025-11-30pass
statement vs summary · operating cash flowconsolidated 2024-06-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2025-06-01/2025-11-30pass
statement vs summary · revenueconsolidated 2024-06-01/2024-11-30pass
statement vs summary · revenueconsolidated 2025-06-01/2025-11-30pass
statement vs summary · total assetsconsolidated 2025-05-31pass
statement vs summary · total assetsconsolidated 2025-11-30pass